04-21-2014, 04:14 AM
.........As analytical instrumentation increased in power and more and more agents were found to be carcinogenic at very low levels, the agencies had developed a quantitative risk assessment approach to interpreting the Delaney Clause, which stated that if a carcinogen was present at levels less than 1 in 1,000,000 parts, the risk of that carcinogen was "de minimis" and it could be allowed on the market.[5] In the article, Taylor presented arguments in favor of this approach. Advocates in favor of organic food have criticized Taylor for taking this stance and have attributed the stance not to a good faith effort to reasonably regulate, but to an alleged desire to benefit Monsanto financially.[6]
On July 17, 1991, Michael Taylor left King & Spalding, returning to the FDA to fill the newly created post of Deputy Commissioner for Policy. During that time, he signed the Federal Register notice stating that milk from cows treated with BGH did not have to be labeled as such.[1][7] His name is not on the FDA’s 1992 policy statement on genetically engineered plant foods,[8] but he is said to have been a co-author.[1] Both of these documents grew out of, and fall within, the regulatory policy framework that was developed starting in the mid-1980s under the Reagan and Bush Administrations...
On July 17, 1991, Michael Taylor left King & Spalding, returning to the FDA to fill the newly created post of Deputy Commissioner for Policy. During that time, he signed the Federal Register notice stating that milk from cows treated with BGH did not have to be labeled as such.[1][7] His name is not on the FDA’s 1992 policy statement on genetically engineered plant foods,[8] but he is said to have been a co-author.[1] Both of these documents grew out of, and fall within, the regulatory policy framework that was developed starting in the mid-1980s under the Reagan and Bush Administrations...